). Secondary structures are in red (helices α1-4) and green (β1, β4 and DSBH βI-βVIII). Apart from their different N-terminal domains (PHD11-164/PHD21-180), conservation is substantially lost in two regions within the catalytic domains: the C-terminus and a flexible 'finger-like' loop between strands 2 and 3 (23/loop, shown boxed in pink) 2, 3 . PHD2 missense mutations as found in patients with erythrocytosis (K291I, P317R and R371H) and cancers (W258R, N293S, G294S, E375V, R396T and Y403C, COSMIC database 4 ) are highlighted by red asterisks. (b) Structure-based alignment of HIF-1α NODD and CODD as observed bound in PHD2 complex structures.
); both Km and kcat for NODD slightly improved (compared to the R281L). To investigate the structural basis of catalytic differences between the wt, R281L and I280V/I292V/R281L PHD2 variants, the triple variant was crystallized in the P63 form; the structure reveals that the multiple substitutions create a wider hydrophobic pocket (compare b and c; f and g) at this site that likely accommodates the leucine more efficiently. Support for this proposal comes from yeast-two hybrid experiments where except for phenylalanine, substitution of Leu574CODD with all other residues is disfavored for a stable interaction with PHD3; PHD2 has a slightly higher preference for valine (shorter) over leucine at this position 14 .
Supplementary Figure 7 | Views from superimposed structures of the G294E variant (grey) with PHD2.CODD (a) and

PHD2.NODD (b).
Modeling studies indicated that the Glu116PHD3 (analogous to Gly278PHD1/Gly294PHD2) side-chain in PHD3 might alter substrate binding when compared to PHD2.CODD/NODD complexes. We tested the effects of Asn293PHD2 and Gly294PHD2, which are located in the C-terminal substrate binding region and are replaced in PHD3 by Lys115PHD3 and Glu116PHD3 on PHD catalysis. The PHD2 G294E and N293K/G294E variants showed 20-25% reductions in NODD, but less significant/unaltered levels of CODD hydroxylations (c). Data are mean and s.e.m. (n≥3). A G294E variant crystal structure reveals local changes around Glu294 (in the variant) especially involving the sidechain of Arg396PHD2 (a and b). In the PHD2.CODD structure (a), Arg396PHD2 moves towards CODD to form a salt-bridge with Asp571CODD compared to PHD2.NODD complex (b), where the residue adopts a conformation that would cause a steric clash with Glu294. In the G294E variant structure, Arg396PHD2 takes a different conformation similar to that observed in the PHD2.Mn.NOG or the PHD2.Fe.2OG complexes 15 , in which it hydrogen bonds with Glu294. Figures (a) and (b) show surface representations of a PHD3.CODD complex that was modelled based on the PHD2.CODD crystal structure (PDB: 5L9B). MD predict that the overall binding of CODD to both PHD2 and PHD3 (and hence CODD conformations in both complexes) is similar (see Supplementary Fig. 3 ). We produced a series of PHD3 point variants with the aim of making PHD3 more 'PHD2 like' to increase its ability to hydroxylate NODD. Of these variants, R65K and L73I PHD3 clearly increased NODD hydroxylation relative to wt PHD3 (25-30% as compared to <10%). A recent study suggests that PHD3 forms oligomers in the presence of metals such as Zn(II), via reaction of two surface cysteines Cys42 and Cys52 that are replaced by Gln221 and Asp231 in PHD2 16 . We produced a double cysteine variant of PHD3 (C42Q/C52D) that manifests improved behavior during purification and P317R crystal structure. P317R PHD2 is the most frequently occurring PHD2 mutation that has been associated with familial erythrocytosis 12, 17 . P317R PHD2 (full-length) has been reported to cause a reduction in HIF-1549-575 hydroxylation (<10% of wt PHD2) in a VHL-capture assay 12 . The PHD2 P317R variant retains (almost) full activity with CODD compared to wt PHD2 (see also All samples were buffered with 50 mM Tris-D11pH 6.6 and 0.02% NaN3 in H2O-D2O (9:1). DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) was used as a reference for chemical shifts. n.d., not performed due to the limited solubility of NODD.  Substrate peptides used, NODD: 395 DALTLLAPAAGDTIISLDF 413 ; CODD:
Supplementary Table 3 | Kinetic analyses of the PHD2 variants for the hydroxylation of CODD (HIF-1556-574) and NODD (HIF-1395-413) substrates employing a MALDI-MS based assay (n = 3-9
556 DLDLEMLAPYIPMDDDFQL 574 ; Data were processed using Bruker TopSpin 3.1, and analyzed using CcpNmr Analysis software 21 .
Supplementary Table 5 Sitting drop (300 nl), proteinto-well ratio, 1:1, 293K *Highest resolution shell shown in parenthesis. **Rsym = ∑|I-<I>|/∑I, where I is the intensity of an individual measurement and <I> is the average intensity from multiple observations. ‡ Rfactor = ∑hkl||Fobs(hkl)| − k |Fcalc(hkl)||/ ∑hkl|Fobs(hkl)| for the working set of reflections; Rfree is the Rfactor for ~5% of the reflections excluded from refinement. *Highest resolution shell shown in parenthesis. **Rsym = ∑|I-<I>|/∑I, where I is the intensity of an individual measurement and <I> is the average intensity from multiple observations. ‡ Rfactor = ∑hkl||Fobs(hkl)| − k |Fcalc(hkl)||/ ∑hkl|Fobs(hkl)| for the working set of reflections; Rfree is the Rfactor for ~5% of the reflections excluded from refinement.
